P37602
5-苯基戊酸
99%
别名:
5-苯基正戊酸
质量水平
方案
99%
表单
crystals
沸点
177-178 °C/13 mmHg (lit.)
mp
58-60 °C (lit.)
SMILES字符串
OC(=O)CCCCc1ccccc1
InChI
1S/C11H14O2/c12-11(13)9-5-4-8-10-6-2-1-3-7-10/h1-3,6-7H,4-5,8-9H2,(H,12,13)
InChI key
BYHDDXPKOZIZRV-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
D M Chung et al.
International journal of biological macromolecules, 29(4-5), 243-250 (2001-11-24)
From a set of mixed carbon sources, 5-phenylvaleric acid (PV) and octanoic acid (OA), polyhydroxyalkanoic acid (PHA) was separately accumulated in the two pseudomonads Pseudomonas putida BM01 and Pseudomonas citronellolis (ATCC 13674) to investigate any structural difference between the two
Marie-Paule Gonthier et al.
Free radical biology & medicine, 35(8), 837-844 (2003-10-15)
Procyanidins are major dietary polyphenols made of elementary flavan-3-ol (epi)catechin units. They have antioxidant properties and may contribute to health benefits in humans, but little is known about their metabolic fate. We compared here the metabolism of procyanidin dimer B3
Christopher Jewell et al.
Drug metabolism and disposition: the biological fate of chemicals, 35(11), 2015-2022 (2007-08-01)
The capacity of human, minipig, and rat skin and liver subcellular fractions to hydrolyze the anesthetic ester procaine was compared with carboxylesterase substrates 4-methylumbelliferyl-acetate, phenylvalerate, and para-nitrophenylacetate and the arylesterase substrate phenylacetate. Rates of procaine hydrolysis by minipig and human
I-Ching Ho et al.
International journal of biological macromolecules, 40(2), 112-118 (2006-08-22)
PHAs (poly-3-hydroxyalkanoates) obtained by Pseudomonas oleovorans grown with mixed carbon sources were investigated. Mixed carbon sources were sodium octanoate/undecylenic acid and sodium octanoate/5-phenylvaleric acid. Effect of carbon source in pre-culture on PHAs structure was investigated. Main fermentation was conducted with
Keishi Yamasaki et al.
Journal of pharmaceutical sciences, 106(9), 2860-2867 (2017-05-01)
Sodium 4-phenylbutyrate (PB) is clinically used as a drug for treating urea cycle disorders. Recent research has shown that PB also has other pharmacologic activities, suggesting that it has the potential for use as a drug for treating other disorders.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持